life scienc tool diagnost
ep ahead consensu hsic ep
continu oper ahead estim stronger
revenu profit rais ep guidanc
midpoint vs con fulli reflect beat
rais ep beat partial off-set
slower oper growth trajectori balanc year pt
move ebitda higher view
greater convict longer term prospect seemingli stabil
pre-cal view share rise hsic share rise latest
healthi top-line perform dental bright spot
america consum trend show sign stabil equip
improv tough comp ahead potenti id ramp intern
increas ep guidanc midpoint
fulli reflect oper upsid note continu
transit year overal recent updat screen
well particularli rel low expect print focu
call underli demand trend capit deploy profit
margin cadenc risk shift demand trend contract renewals/loss
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
provid product servic office-bas dental
anim health medic practition
price may rate neutral target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
revenu profit ahead revenu increas ahead includ
intern cc growth incl tsa dental intern growth acceler
vs america consum par
experi stronger equip vs medic intern growth
deceler vs technolog improv modestli vs
plan gross margin expand bp bp
plan admin expens decreas bp yoy bp better plan
ebitda margin increas bp bp plan gener million cash
vs million help fund million share repurchas
reserv stand million
charl martineau pm univers toronto compani mention price
